Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

The highly recurrent PP2A Aα-subunit mutation P179R alters protein structure and impairs PP2A enzyme function to promote endometrial tumorigenesis.

Taylor SE, O'Connor CM, Wang Z, Shen G, Song H, Leonard D, Sangodkar J, LaVasseur C, Avril S, Waggoner S, Zanotti K, Armstrong AJ, Nagel C, Resnick K, Singh S, Jackson MW, Xu W, Haider S, DiFeo A, Narla G.

Cancer Res. 2019 May 29. pii: canres.0218.2019. doi: 10.1158/0008-5472.CAN-19-0218. [Epub ahead of print]

PMID:
31142515
2.

The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.

Doherty MR, Parvani JG, Tamagno I, Junk DJ, Bryson BL, Cheon HJ, Stark GR, Jackson MW.

Breast Cancer Res. 2019 Apr 29;21(1):54. doi: 10.1186/s13058-019-1136-x.

3.

Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells.

Taylor WR, Fedorka SR, Gad I, Shah R, Alqahtani HD, Koranne R, Kuganesan N, Dlamini S, Rogers T, Al-Hamashi A, Kholodovych V, Barudi Y, Junk D, Rashid MS, Jackson MW, Tillekeratne LMV.

Sci Rep. 2019 Apr 11;9(1):5926. doi: 10.1038/s41598-019-42251-5.

4.

Septal Hematoma: A Rare But Potentially Serious Complication of Retrograde CTO-PCI.

Jackson MWP, Lee D, Egred M.

J Invasive Cardiol. 2019 Mar;31(3):E47-E48.

5.

Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis.

Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R.

Leuk Lymphoma. 2019 May;60(5):1234-1243. doi: 10.1080/10428194.2018.1522435. Epub 2018 Dec 3.

PMID:
30501432
6.

Liposomal Bupivacaine Transversus Abdominis Plane Block Versus Epidural Analgesia in a Colon and Rectal Surgery Enhanced Recovery Pathway: A Randomized Clinical Trial.

Felling DR, Jackson MW, Ferraro J, Battaglia MA, Albright JJ, Wu J, Genord CK, Brockhaus KK, Bhave RA, McClure AM, Shanker BA, Cleary RK.

Dis Colon Rectum. 2018 Oct;61(10):1196-1204. doi: 10.1097/DCR.0000000000001211.

PMID:
30192328
7.

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer.

Doherty MR, Jackson MW.

Oncoscience. 2018 Jun 28;5(5-6):169-171. doi: 10.18632/oncoscience.438. eCollection 2018 May. No abstract available.

8.

Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes.

Jackson MWP, Austin D, Swanson N, Williams PD, Muir DF, Hall JA, Wright RA, Sutton AGC, Carter J, de Belder MA.

Coron Artery Dis. 2018 Nov;29(7):564-572. doi: 10.1097/MCA.0000000000000646.

PMID:
29944476
9.

A cell-based assay for the detection of pathogenic anti-voltage-gated calcium channel autoantibodies in immunoglobulin G from patients with type 1 diabetes.

Alshehri AM, Mendis T, Jackson MW.

J Immunol Methods. 2018 Sep;460:79-86. doi: 10.1016/j.jim.2018.06.012. Epub 2018 Jun 22.

PMID:
29940155
10.

The Critical, Clinical Role of Interferon-Beta in Regulating Cancer Stem Cell Properties in Triple-Negative Breast Cancer.

Doherty MR, Jackson MW.

DNA Cell Biol. 2018 Jun;37(6):513-516. doi: 10.1089/dna.2018.4247. Epub 2018 May 11.

11.

Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.

Jackson MWP, Muir DF, de Belder MA, Palmer S, Owens WA, Goodwin A, Hayat U, Williams PD.

Heart Lung Circ. 2019 Apr;28(4):637-646. doi: 10.1016/j.hlc.2018.02.025. Epub 2018 Mar 10.

PMID:
29685717
12.

Breaking the oncostatin M feed-forward loop to suppress metastasis and therapy failure.

Smigiel J, Parvani JG, Tamagno I, Polak K, Jackson MW.

J Pathol. 2018 May;245(1):6-8. doi: 10.1002/path.5063. Epub 2018 Apr 2.

PMID:
29473175
13.

Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.

Smigiel JM, Parameswaran N, Jackson MW.

Cancers (Basel). 2018 Jan 10;10(1). pii: E14. doi: 10.3390/cancers10010014. Review.

14.

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, Ford JM, Stark GR, Jackson MW.

Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11.

15.

CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression.

Yu S, Parameswaran N, Li M, Wang Y, Jackson MW, Liu H, Xin W, Zhou L.

Oncotarget. 2016 Dec 26;8(32):52432-52444. doi: 10.18632/oncotarget.14194. eCollection 2017 Aug 8.

16.

Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.

Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM.

Clin Breast Cancer. 2018 Jun;18(3):220-228. doi: 10.1016/j.clbc.2017.06.009. Epub 2017 Jun 29.

PMID:
28797765
17.

Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis.

Stokes WA, Robin TP, Jackson MW, Amini A, Schefter TE, Lefkowits CC, Fisher CM.

Am J Clin Oncol. 2018 Oct;41(10):927-932. doi: 10.1097/COC.0000000000000396.

PMID:
28654573
18.

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.

Bartel CA, Jackson MW.

PLoS One. 2017 May 2;12(5):e0176778. doi: 10.1371/journal.pone.0176778. eCollection 2017.

19.

Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.

Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ.

Brachytherapy. 2017 Jul - Aug;16(4):790-796. doi: 10.1016/j.brachy.2017.03.007. Epub 2017 Apr 23.

PMID:
28442277
20.

Temporal and spatial comparisons of the reproductive biology of northern Gulf of Mexico (USA) red snapper (Lutjanus campechanus) collected a decade apart.

Kulaw DH, Cowan JH Jr, Jackson MW.

PLoS One. 2017 Mar 29;12(3):e0172360. doi: 10.1371/journal.pone.0172360. eCollection 2017.

21.

Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.

Junk DJ, Bryson BL, Smigiel JM, Parameswaran N, Bartel CA, Jackson MW.

Oncogene. 2017 Jul 13;36(28):4001-4013. doi: 10.1038/onc.2017.33. Epub 2017 Mar 13.

22.

Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.

Parvani JG, Jackson MW.

Endocr Relat Cancer. 2017 Apr;24(4):R81-R97. doi: 10.1530/ERC-16-0482. Epub 2017 Feb 1. Review.

23.

The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma.

Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG.

J Thorac Oncol. 2017 Apr;12(4):734-744. doi: 10.1016/j.jtho.2017.01.002. Epub 2017 Jan 25.

24.

Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.

Smigiel JM, Parameswaran N, Jackson MW.

Mol Cancer Res. 2017 Apr;15(4):478-488. doi: 10.1158/1541-7786.MCR-16-0337. Epub 2017 Jan 4.

25.

STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Bryson BL, Junk DJ, Cipriano R, Jackson MW.

Cell Cycle. 2017 Feb 16;16(4):319-334. doi: 10.1080/15384101.2016.1259037. Epub 2016 Nov 28.

26.

IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.

Wang JJ, Al Kindi MA, Colella AD, Dykes L, Jackson MW, Chataway TK, Reed JH, Gordon TP.

Clin Immunol. 2016 Dec;173:57-63. doi: 10.1016/j.clim.2016.09.001. Epub 2016 Sep 5.

PMID:
27609500
27.

Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer.

Merry CR, McMahon S, Forrest ME, Bartels CF, Saiakhova A, Bartel CA, Scacheri PC, Thompson CL, Jackson MW, Harris LN, Khalil AM.

Oncotarget. 2016 Aug 16;7(33):53230-53244. doi: 10.18632/oncotarget.10637.

28.

Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.

Jackson MW, Amini A, Jones BL, Rusthoven CG, Schefter TE, Goodman KA.

Cancer J. 2016 Jul-Aug;22(4):237-42. doi: 10.1097/PPO.0000000000000213.

PMID:
27441741
29.

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.

Bartel CA, Parameswaran N, Cipriano R, Jackson MW.

Oncotarget. 2016 Aug 9;7(32):52597-52612. doi: 10.18632/oncotarget.9544. Review.

30.

Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53.

Karan G, Wang H, Chakrabarti A, Karan S, Liu Z, Xia Z, Gundluru M, Moreton S, Saunthararajah Y, Jackson MW, Agarwal MK, Wald DN.

Mol Cancer Ther. 2016 Apr;15(4):574-582. doi: 10.1158/1535-7163.MCT-15-0467. Epub 2016 Feb 16.

31.

The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.

Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM.

Ann Oncol. 2016 May;27(5):818-27. doi: 10.1093/annonc/mdw046. Epub 2016 Feb 9.

PMID:
26861597
32.

Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.

Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R.

Am J Hematol. 2016 May;91(5):476-80. doi: 10.1002/ajh.24325. Epub 2016 Apr 4.

33.

Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base.

Amini A, Jones BL, Jackson MW, Rusthoven CG, Maroni P, Kavanagh BD, Raben D.

Brachytherapy. 2016 Mar-Apr;15(2):136-46. doi: 10.1016/j.brachy.2015.11.006. Epub 2016 Jan 26.

PMID:
26825856
34.

Secreted autoantibody repertoires in Sjögren's syndrome and systemic lupus erythematosus: A proteomic approach.

Al Kindi MA, Colella AD, Chataway TK, Jackson MW, Wang JJ, Gordon TP.

Autoimmun Rev. 2016 Apr;15(4):405-10. doi: 10.1016/j.autrev.2016.01.008. Epub 2016 Jan 22. Review.

PMID:
26804757
35.

Cocaine-Induced Coronary Vasospasm Using Optical Coherence Tomography Imaging to Guide Management.

Jackson MWP, Williams PD.

JACC Cardiovasc Interv. 2016 Feb 8;9(3):e27-e28. doi: 10.1016/j.jcin.2015.10.046. Epub 2016 Jan 6. No abstract available.

36.

Cancer Stem Cell Plasticity Drives Therapeutic Resistance.

Doherty MR, Smigiel JM, Junk DJ, Jackson MW.

Cancers (Basel). 2016 Jan 5;8(1). pii: E8. doi: 10.3390/cancers8010008. Review.

37.

[In process.]

Jackson MW.

Acta Hist Leopoldina. 2016;(65):65-81. German.

PMID:
29489115
38.

New-Onset Heart Failure in a Patient With a Pacemaker: An Unusual Cause.

Jackson MW, Taylor RJ.

JAMA Intern Med. 2016 Jan;176(1):110-1. doi: 10.1001/jamainternmed.2015.6543. No abstract available.

PMID:
26595061
39.

A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome.

Bastian I, Gordon TP, Jackson MW.

J Immunol Methods. 2015 Dec;427:117-21. doi: 10.1016/j.jim.2015.11.005. Epub 2015 Nov 14.

PMID:
26584897
40.

Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base.

Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D.

J Urol. 2016 May;195(5):1453-1458. doi: 10.1016/j.juro.2015.11.005. Epub 2015 Nov 11.

PMID:
26576709
41.

Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.

Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):126-132. doi: 10.1016/j.ijrobp.2015.09.017. Epub 2015 Sep 25.

PMID:
26547384
42.

DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer.

Merry CR, Forrest ME, Sabers JN, Beard L, Gao XH, Hatzoglou M, Jackson MW, Wang Z, Markowitz SD, Khalil AM.

Hum Mol Genet. 2015 Nov 1;24(21):6240-53. doi: 10.1093/hmg/ddv343. Epub 2015 Aug 25.

43.

Serum SmD autoantibody proteomes are clonally restricted and share variable-region peptides.

Al Kindi MA, Chataway TK, Gilada GA, Jackson MW, Goldblatt FM, Walker JG, Colella AD, Gordon TP.

J Autoimmun. 2015 Feb;57:77-81. doi: 10.1016/j.jaut.2014.12.005. Epub 2015 Jan 7.

PMID:
25577500
44.

The biology of race: searching for no overlap.

Jackson MW.

Perspect Biol Med. 2014 Winter;57(1):87-104. doi: 10.1353/pbm.2014.0011.

PMID:
25345704
45.

Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence.

Jackson MW, Rusthoven CG, Fisher CM, Schefter TE.

Onco Targets Ther. 2014 May 16;7:751-9. doi: 10.2147/OTT.S49429. eCollection 2014. Review.

46.

Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.

Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW.

Mol Cancer Res. 2014 Aug;12(8):1156-65. doi: 10.1158/1541-7786.MCR-13-0289. Epub 2014 Apr 15.

47.

HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression.

Junk DJ, Bryson BL, Jackson MW.

Cancers (Basel). 2014 Mar 26;6(2):741-55. doi: 10.3390/cancers6020741.

48.

ETV1 positively regulates transcription of tumor suppressor ARF.

Zynda E, Jackson MW, Bhattacharya P, Kandel ES.

Cancer Biol Ther. 2013 Dec;14(12):1167-73. doi: 10.4161/cbt.26883. Epub 2013 Oct 23.

49.

Coordinated regulation of p31(Comet) and Mad2 expression is required for cellular proliferation.

Date DA, Burrows AC, Venere M, Jackson MW, Summers MK.

Cell Cycle. 2013 Dec 15;12(24):3824-32. doi: 10.4161/cc.26811. Epub 2013 Oct 15.

50.

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.

Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR.

EMBO J. 2013 Oct 16;32(20):2751-63. doi: 10.1038/emboj.2013.203. Epub 2013 Sep 24.

Supplemental Content

Loading ...
Support Center